Topical imiquimod in the treatment of extramammary Paget's disease: A 10 year retrospective analysis in an Asian tertiary centre | Zendy

Liau MeiQi May | Zendy; Yang Shiyao Sam | Zendy; Tan Kong Bing | Zendy; Aw Chen Wee Derrick | Zendy

Premium

Topical imiquimod in the treatment of extramammary Paget's disease: A 10 year retrospective analysis in an Asian tertiary centre

Author(s) -

Liau MeiQi May,

Yang Shiyao Sam,

Tan Kong Bing,

Aw Chen Wee Derrick

Publication year - 2016

Publication title -

dermatologic therapy

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.595

H-Index - 68

eISSN - 1529-8019

pISSN - 1396-0296

DOI - 10.1111/dth.12394

Subject(s) - medicine , imiquimod , dermatology , extramammary paget's disease , paget disease , apocrine , disease , pathology

Extramammary Paget's disease (EMPD) is a rare intraepithelial adenocarcinoma usually found in apocrine‐rich areas. Although surgery remains standard treatment, topical imiquimod has emerged as a promising drug for the treatment of EMPD in recent years. We present our experience in treating EMPD in Asian skin successfully with topical imiquimod 5% cream, over the past 10 years in our tertiary institution.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here

Accelerating Research